T. Rowe Price Health Care ETF
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
5.3%
1 yr return
N/A
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$20.1 M
Holdings in Top 10
44.6%
52 WEEK LOW AND HIGH
$31.7
$23.61
$31.75
Expenses
OPERATING FEES
Expense Ratio 0.44%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
TMED - Profile
Distributions
- YTD Total Return 5.3%
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.5%
- Dividend Distribution Frequency Other
Fund Details
-
Legal NameT. Rowe Price Health Care ETF
-
Fund Family NameTROWEPRICE
-
Inception DateJun 12, 2025
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
Fund Description
p id="xdx_A8B_eoef--StrategyNarrativeTextBlock_zdlfTtAQ9nCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"span id="xdx_90D_eoef--StrategyPortfolioConcentration_c20260225__20260225__dei--LegalEntityAxis__custom--S000092023Member_zLQBDSyqutL7"The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies./span The fund defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund references the MSCI GICS (Global Industry Classification Standard) Health Care sector to identify such companies. Any derivatives that provide exposure to the investment focus suggested by the fund’s name, or to one or more market risk factors associated with the investment focus suggested by the fund’s name, are counted (as applicable) toward compliance with the fund’s 80% investment policy./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"As a fundamental policy, the fund will concentrate (invest more than 25% of its net assets) in health care companies./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The majority of the fund will be invested in equity securities, such as common stocks. While most assets are typically invested in U.S. common stocks, the fund may invest in foreign stocks in keeping with its objective./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The fund uses fundamental, bottom-up analysis and may invest in companies of any market capitalization. The adviser may use both growth and value approaches in selecting investments for the fund./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"The fund is nondiversified, which means it may invest a greater percentage of its assets in a particular issuer than is permissible for a diversified fund./p p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0" /p
Read More
TMED - Performance
Return Ranking - Trailing
| Period | TMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.3% | N/A | N/A | N/A |
| 1 Yr | N/A | N/A | N/A | N/A |
| 3 Yr | N/A* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Return Ranking - Calendar
| Period | TMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
Total Return Ranking - Trailing
| Period | TMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.3% | N/A | N/A | N/A |
| 1 Yr | N/A | N/A | N/A | N/A |
| 3 Yr | N/A* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | TMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
TMED - Holdings
Concentration Analysis
| TMED | Category Low | Category High | TMED % Rank | |
|---|---|---|---|---|
| Net Assets | 20.1 M | N/A | N/A | N/A |
| Number of Holdings | 109 | N/A | N/A | N/A |
| Net Assets in Top 10 | 9.03 M | N/A | N/A | N/A |
| Weighting of Top 10 | 44.58% | N/A | N/A | N/A |
Top 10 Holdings
- ELI LILLY + CO COMMON STOCK 14.48%
- UNITEDHEALTH GROUP INC COMMON STOCK USD.01 6.54%
- THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 4.59%
- GILEAD SCIENCES INC COMMON STOCK USD.001 4.14%
- ABBOTT LABORATORIES COMMON STOCK 3.91%
- DANAHER CORP COMMON STOCK USD.01 2.73%
- MEDTRONIC PLC COMMON STOCK USD.1 2.24%
- ALNYLAM PHARMACEUTICALS INC COMMON STOCK USD.01 2.06%
- STRYKER CORP COMMON STOCK USD.1 2.00%
- DYNE THERAPEUTICS INC COMMON STOCK USD.0001 1.88%
Asset Allocation
| Weighting | Return Low | Return High | TMED % Rank | |
|---|---|---|---|---|
| Stocks | 99.76% | N/A | N/A | N/A |
| Cash | 0.60% | N/A | N/A | N/A |
| Preferred Stocks | 0.00% | N/A | N/A | N/A |
| Other | 0.00% | N/A | N/A | N/A |
| Convertible Bonds | 0.00% | N/A | N/A | N/A |
| Bonds | 0.00% | N/A | N/A | N/A |
Stock Sector Breakdown
| Weighting | Return Low | Return High | TMED % Rank | |
|---|---|---|---|---|
| Utilities | 0.00% | N/A | N/A | N/A |
| Technology | 0.00% | N/A | N/A | N/A |
| Real Estate | 0.00% | N/A | N/A | N/A |
| Industrials | 0.00% | N/A | N/A | N/A |
| Healthcare | 0.00% | N/A | N/A | N/A |
| Financial Services | 0.00% | N/A | N/A | N/A |
| Energy | 0.00% | N/A | N/A | N/A |
| Communication Services | 0.00% | N/A | N/A | N/A |
| Consumer Defense | 0.00% | N/A | N/A | N/A |
| Consumer Cyclical | 0.00% | N/A | N/A | N/A |
| Basic Materials | 0.00% | N/A | N/A | N/A |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | TMED % Rank | |
|---|---|---|---|---|
| US | 99.51% | N/A | N/A | N/A |
| Non US | 0.25% | N/A | N/A | N/A |
TMED - Expenses
Operational Fees
| TMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.44% | N/A | N/A | N/A |
| Management Fee | 0.44% | N/A | N/A | N/A |
| 12b-1 Fee | N/A | N/A | N/A | N/A |
| Administrative Fee | N/A | N/A | N/A | N/A |
Sales Fees
| TMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | N/A | N/A | N/A |
| Deferred Load | N/A | N/A | N/A | N/A |
Trading Fees
| TMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| TMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | N/A | N/A | N/A |
TMED - Distributions
Dividend Yield Analysis
| TMED | Category Low | Category High | TMED % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.52% | N/A | N/A | N/A |
Dividend Distribution Analysis
| TMED | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Other |
Net Income Ratio Analysis
| TMED | Category Low | Category High | TMED % Rank | |
|---|---|---|---|---|
| Net Income Ratio | N/A | N/A | N/A | N/A |
Capital Gain Distribution Analysis
| TMED | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency |